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ABSTRACT 
Objective: To evaluate the regeneration of mandibular cartilage defect after implantation of human 
umbilical cord mesenchymal stem cells (hUCMSC) over platelet rich fibrin (PRF) as scaffold. Material and 
Methods: 20 male Wistar rats were randomly divided into four experimental groups consisting of: a 
control group featuring untreated mandibular defects (C), experimental groups whose mandibular defects 
were implanted with hUCMSC (E1), mandibular defects implanted with PRF (E2), mandibular defects 
implanted with hUCMSC and PRF scaffold (E3). The subjects were sacrificed after six weeks of observation 
for immunohistochemical examination in order to evaluate the expression of Ki67, Sox9, FGF 18, type 2 
collagen, and aggrecan, in addition to histology examination to evaluate chondrocyte number and cartilage 
thickness. Data was analyzed with univariate analysis (ANOVA). Results: The implantation of hUCMSC 
and PRF scaffold proved capable of regenerating mandibular cartilage defect through the expression of 
FGF 18, Sox9, Ki67, chondrosis counts, type 2 collagen, aggrecan, and cartilage thickness. The 
regeneration were significantly higher in group E3. Conclusion: Human umbilical cord mesenchymal stem 
cells in platelet rich fibrin scaffold proved capable of regenerating mandibular cartilage defect. 
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Introduction 
Mandibular cartilage defect can be caused by micro and macro trauma [1] resulting in debilitating 
effects such as prolonged pain, function impairment, chronic inflammation and progressive cartilage 
degeneration [2]. In fact, mandibular cartilage defect in children may impair mandibular growth [3]. Post-
trauma cartilage degeneration occurs because of low regenerative capacity due to the avascular, alimphatic and 
aneural nature of articular cartilage and chondrocyte in a low turn-over to maintain extracellular matrix [4]. 
Various methods that had been developed in orthopedics to reconstruct cartilage defects such as 
subchondral drilling, abrasion, microfracture, mosaicplasty, autologous chondrocyte implantation and matrix-
assisted autologous chondrocyte implantation, have not yet been proven capable of providing a long and well-
functioning cartilage in an extensive defect [5]. Autologous chondrocyte injection initiated in 1994 by 
Brittberg et al. [6] suffered from several disadvantages: limited cell procurement, donor site morbidity and 
limited potential for proliferation and differentiation [7]. In Oral and Maxillofacial Surgery, reconstruction of 
cartilage defect using autograft, allograft, and allopalstic material pose several disantantages and complication 
such as injury to facial nerve and temporomandibular nerve, and Frey’s syndrome [1]. 
Cartilage generation requires a sufficient number of cells to replace damaged chondrocytes. 
Mesenchymal stem cells (MSCs) were considered a potential source in cartilage regeneration and engineering 
because of their high expansion rate [8]. The umbilical cord is a potential source of MSCs with several 
advantages such as being procured ethically from biological waste and demonstrating a high expansion rate 
[9]. 
Stem cell implantation requires scaffold for cell growth and development. Platelet rich fibrin (PRF) is 
a natural fibrin matrix polymer, attracting fibroblast and undifferentiated cells into the matrix. PRF also 
contains growth factors such as PDGF-β, TGFβ-1, VEGF, IGF-I, IL-1β, IL-6, IL-4 and TNF-α [10]. 
However, regeneration of mandibular cartilage defects through the implantation of hUCMSC over PRF 
scaffold remains to be studied. 
This study was performed to evaluate regeneration of surgically created mandibular cartilage defects 
in rat subjects after implantation of hUCMSC over PRF scaffold through expression of FGF 18, Sox9, Ki67, 
chondrocyte counts, type 2 collagen, aggrecan, and cartilage thickness. FGF 18 regulates chondrocyte 
proliferation, produces ECM and proteoglican. It attaches to FGFR-3 that cause anabolic effect in cartilage 
formation [11]. 
 
Material and Methods 
Preparation of Experimental Subjects 
This study was conducted following the granting of Ethical Clearance by the Animal Care and Use 
Committee, Faculty of Veterinary Medicine, Universtas Airlangga, Indonesia; number 430-KE, 14 April 2015 
and constituted a true experimental post-test only control group study. Twenty male, albinus strain Rattus 
novergicus aged three months and 200-300 grams in weight were used as animal subjects. These were randomly 
divided into four experimental groups, consisting of: (C) a control group with untreated mandibular defects, 
(E1) experiment groups had mandibular defects implanted with hUCMSC, (E2) mandibular defects implanted 
with PRF (E3) mandibular defects implanted with hUCMSC and PRF scaffold. 
 
Human Umbilical Cord Mesenchymal Stem Cell Isolation and Expansion Culture 
An umbilical cord was obtained from a healthy C-section birth at Dr. Soetomo Public Hospital, 
Surabaya, Indonesia. Isolation and expansion culture were conducted according to the protocols of the Stem 
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Cell Research and Development Center, Institute of Tropical Disease, Universitas Airlangga, Indonesia. 
Characterisation of MSC was conducted prior to implantation by means of immunocytochemical and 
flowcytometric analysis [12]. 
 
Preparation of PRF 
After an animal subject had been anaesthetized with Ketamin/Xylazin, 1.5 ml of venous blood were 
aspirated from its tail. The blood was obtained using a 3 ml disposable syringe without anticoagulant and 
centrifuged at 3,000 rpm for ten minutes until it separated into three layers, the middle layer being PRF. 
 
Implantation of hUCMSC, PRF and hUCMSC and PRF 
Mandibular cartilage defects were created surgically in the anterior portion of the condylar superior 
surface using a round bur 1mm in diameter [13]. Two million (2 x 106) hUCMSC pellets were implanted in 
group E1, 1 mm of PRF was implanted in group E2, while group E3 was implanted with hUCMSC seeded in 1 
mm PRF through centrifugation at 3,000 rpm for five minutes. After the defects had been fully covered, the 
wound was sutured in layers. 
 
Specimens Preparation and Microscopic Examination 
The subjects were sacrificed after a 6-week period of observation. The mandible was subsequently 
exarticulated and fixated with 20% formalin for two days at room temperature and decalcified in 10% 
Ethylenediaminee tetra-acetic (EDTA) for eight weeks before being embedded in paraffin. Each paraffin block 
was cut axially to a thickness of 4 μm, deparaffinized and dehydrated. Specimens were then stained with Harris 
Hematoxylin-Eosin to enable histological examination to be conducted in order to evaluate chondrocyte counts 
and cartilage thickness. Immunohistochemical examination was undertaken to evaluate expression of FGF18 
using polyclonal anti FGF18 (PAC907Mu01) antibodies, Cloud-Clone Corp, USA), expression of Sox9 using 
polyclonal anti Sox9 (sc-20095) antibodies, Santa Cruz Biotechnology, Inc, USA), expression of Ki67 using 
polyclonal anti Ki67 (sc-15402) antibodies, Santa Cruz Biotechnology, Inc, USA), expression of type 2 collagen 
using polyclonal anti Coll2 antibodies (sc-7763, Santa Cruz Biotechnology, Inc, USA) and expression of 
aggrecan using polyclonal anti aggrecan antibodies (GTX54920, GeneTex, USA). Cell number were average 
number of cells counted manually in 20 visual field under light microscope. 
 
Statistical Analysis 
Data analyzed with univariate analysis (ANOVA) using SPSS software version 21.0 (IBM SPSS, Inc, 
Chicago, IL, USA) at P < 0.05 was considered statistically significant. 
 
Ethical Clearance 
This study received ethical approval from the Ethical Committee Dr. Soetomo General Hospital 
Surabaya, Indonesia (Number 379/Panke.KKE/VII/2015). 
 
Results 
Isolation and Culture of Human Umbilical Cord Mesenchymal Stem Cells 
hUCMSC previously isolated and cultured displayed the character of MSC that expressed surface 
markers such as CD45-, CD73+, CD90+, CD105+. 
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Expression of Ki67, FGF18, Sox9 and chondrocyte numbers 
The proliferation of hUCMSC and its differentiation into chondrocyte were evidenced by the 
expression of Ki67, FGF18, Sox9 and chondrocyte numbers. Microscopic images of cells expressing Ki67, 
FGF18, Sox9, and chondrocyte counts are contained in Figure 1. Mean and deviation standard values for each 
proliferation and differentiation variable are presented in Figure 2. 
 
 
Figure 1. Microscopic image of immunohistochemical staining of cells expressing ki67 (A), FGF18 (B), 
Sox9 (C), and HE staining of chondrocyte counts (D). Examination was carried out under light 
microscope, at 400x magnification. Black arrows show cells expressing Ki67, FGF 18, Sox9 and 
Chondrocyte. 
 
 
Figure 2. Graph of mean value and deviation standard of each group, expression of Ki67 (A), expression 
of FGF 18 (B), expression of Sox9 (C), Chondrocyte counts (D). Different superscript shows the 
statistical difference between groups (p<0.05). 
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Expression of Type 2 Collagen, Aggrecan and Cartilage Thickness 
Matrix deposition was represented by the expression of type 2 collagen and aggrecan, whereas the 
regeneration of cartilage was evidenced by cartilage thickness. Microscopic images of cells expressing type 2 
collagen and aggrecan, as well as cartilage thickness; the mean and deviation standard values of each matrix 
deposition and regeneration variable are presented in Figure 3. 
 
 
Figure 3. Microscopic image of immunohistochemical staining of cells expressing type 2 collagen (A) 
and aggrecan (B). Black arrows show cells expressing type II collagen and aggrecan. Examination was 
carried out under a light microscope at 400x magnification. HE staining of cartilage thickness (C), 
black arrow shows defects in the proliferative and mature zone, green arrows indicate the fibrous zone, 
yellow arrows indicate the mature zone, brown arrows indicate the hypertrophic zone and blue arrows 
indicate the subchondral bone (light microscope at 100x magnification). Graph of the mean value and 
deviation standard of each group, expression of type II collagen (D), aggrecan (E), cartilage thickness 
(F). Different superscript showed statistical differences between groups (p<0.05). 
 
Discussion 
The implantation of hUCMSC over PRF scaffold underwent proliferation and differentiation into 
chondrocytes to initiate extracellular matrix deposition. This, in turn, regenerated defective cartilage through 
a complex process involving various growth factors of FGF18 and transcription factor of Sox9. In this study, 
the surface markers found were CD45-, CD73+, CD90+, CD105+, as previously described [14]. 
The proliferation of hUCMSC and chondocyte differentiation were significantly higher in the E3 
group compared to other groups. This may be caused by the nature of PRF being a flexible, elastic and 
extremely strong fibrin matrix that fulfils the 3-dimensional requirement for biomaterial. In addition, growth 
factors, platelets and immune concentrate that are required in the healing and immune process were all 
released [15,16]. Seeding of hUCMSC in PRF in this study was accomplished through centrifugation where 
PRF had undergone polymerization that reduces thrombin concentration, thus forming tetramolecular and 
trimolecular bonds or extensive 3D equilateral bonds. This bonding promotes cytokin attachment, cell 
migration and retains stem cells within the PRF, chemotactically recruited MSC, caused by dense fibrin 
structure increasing growth factor and resulting in the gradual release of other mediators. This process will 
confine hUCMSC to the PRF [17,18]. 
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The high proliferation of hUCMSC in PRF scaffold was demonstrated by the strong expression of 
Ki67 which results from PRF also constituting an extracellular matrix that forms tissue structure, provides 
regulatory signal for cell proliferation and differentiation through cell-receptor interaction, mediating diffusion 
of soluble growth factors and reducing mechanical signals [19]. Platelet-derived growth factor contained in 
PRF might induce cell proliferation through Akt signal transduction that is important in cell proliferation 
[20,21]. The strong expression of Ki67 was consistent with high chondrocyte counts. 
High chondrocyte counts will express significant FGF 18. This study found the highest expression of 
FGF 18 to be in E3 group compared to the other groups in the experiment that showed no significant 
difference. Chondrogenic differentiation was indicated by high expression of FGF18, that was a physiological 
ligand of FGFR3 [22]. Columnar and flat chondrocyte represent the most proliferative cells in cartilage 
expressing high FGFR3 [23] enhanced chondrogenic differentiation and cartilage production through 
increased expression of type 2 collagen [24]. High expression of Sox9 caused induction of chondrogenesis 
through Smad2/3 [25], influencing morphogenesis of the condyle [26]. Bond of Sox9 in chondocyte specific 
enhancer in intron 1gen pro-α1 type 2 collagen upregulating the synthesis of α1 type 2 collagen, Sox9 
maintained its high expression in fully differentiated chondrocyte [27]. This study also showed the highest 
expression of Sox9 to occur after 6 weeks’ implantation of hUCMSC in PRF scaffold. Expression of Sox9 
might be regulated by FGFR3 [28], as was indicated by the findings reported here that showed high 
expression of FGF18, Sox9, and type 2 collagen, as well as aggrecan. 
The collagen network in articular cartilage provides mechanical support to tensile forces generated by 
compression or interstitial swelling, protects chondrocyte, maintains proteoglycan attachment and attaches 
cartilage to subchondral bone [29]. Type 2 collagen and aggrecan were molecular markers of mature 
chondrocyte because they were produced by differentiated chondocytes [30]. This study confirmed a 
significant difference of type II collagen and aggrecan expression in hUCMSC in PRF scaffold compared to 
other groups consistent with the high expression of Sox9. FGF 18 released in large quantities in E3 group will 
upregulate Sox9 expression at several stages of chondrocyte differentiation, increase proteoglycan deposition, 
aggrecan and type II collagen expression and significantly decrease expression of collagen type I [31]. 
Regeneration of mandibular cartilage defects in hUCMSC in PRF scaffold was indicated by the 
highest mean of cartilage thickness. The interaction of chondrocyte and extracellular matrix regulates 
important processes in homeostasis and cartilage repair mediated by integrin signalling. The mechanical 
nature of scaffold plays an important role in tissue regeneration and at the cellular level, which affects 
mesenchymal stem cell differentiation [32]. The proliferation of hUMCSC and its differentiation into 
chondrocyte leads the latter to produce extracellular matrices such as type II collagen and aggrecan. In 
addition to the growth factor released by PRF, it also provides the mechanical structure required in promoting 
cartilage thickness. Extracellular matrices provided by PRF not only form tissue structure and function, but 
also provide regulatory signals for cell proliferation and differentiation through cell-receptor interaction, 
mediating soluble growth factor diffusion and absorbing mechanical signals [21]. 
 
Conclusion 
Human umbilical cord mesenchymal stem cells in platelet rich fibrin scaffold proved capable of 
regenerating mandibular cartilage defect. 
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